Community Oncology and Prevention Trials

Supports clinical oncology trials in cancer prevention and control in community settings. Funds investigator-initiated research in supportive, palliative and end-of-life care. Coordinates with other NCI programs to conduct clinical oncology research projects in the community setting.

On This Page

All Headings will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Name, Email, Phone	Room	Group(s)/Office	ID
Heckman-Stoddard, Brandy, Ph.D., M.P.H. brandy.heckman-stoddard@nih.gov 240-276-7048	5E334	Chief \| Breast and Gynecologic Cancer Acting Chief \| Community Oncology and Prevention Trials	574
Lee, Beverly beverly.lee@nih.gov 240-614-3425	5E532	Program Officer \| Community Oncology and Prevention Trials	2247
Lee, Cecilia, Dr.P.H., RN cecilia.lee@nih.gov 240-276-7152	5E516	Nurse Consultant \| Community Oncology and Prevention Trials	583
Maxwell, Pamela pamela.maxwell@nih.gov 240-276-7081	5E434	Program Specialist \| Community Oncology and Prevention Trials	586
McCarty, Larae larae.mccarty@nih.gov 240-276-5777	5E322	Program Specialist \| Community Oncology and Prevention Trials Early Detection	2611
Parker, Bernard, M.D., FACP bernard.parker@nih.gov 240-276-5533	5E448	Program Officer \| Community Oncology and Prevention Trials	600
Streck, Brennan, Ph.D., RN, M.P.H. brennan.streck@nih.gov 240-276-7050	5E430	Program Officer \| Breast and Gynecologic Cancer Program Officer \| Community Oncology and Prevention Trials	2465
White, Vanessa A., M.P.H. vanessa.white@nih.gov 240-276-6163	5E524	Program Officer \| Breast and Gynecologic Cancer Program Officer \| Community Oncology and Prevention Trials	2575
Whitman, Cynthia, B.S. [C] cynthia.whitman@nih.gov 240-276-7068	5E524	Contractor \| Community Oncology and Prevention Trials	640

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Prigerson, Holly Gwen	Weill Medical Coll Of Cornell Univ United States	Behavioral and Psychosocial Effects on Study Outcomes in End-Stage Cancer Treatment (BEST End-Stage Cancer Study)	5R35CA197730-10	Brennan Streck, Ph.D., RN, M.P.H.
Rini, Christine	Northwestern University At Chicago United States	Web-based Pain Coping Skills Training to Improve Pain and Poor Adherence caused by Aromatase Inhibitor-Associated Arthralgia In Breast Cancer Survivors (SKIP-Arthralgia): A Randomized Controlled Trial	5R01CA271220-03	Brennan Streck, Ph.D., RN, M.P.H.
Ross, Stephen	New York University School Of Medicine United States	Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress	5R01CA268521-03	Rachel Altshuler, Ph.D.
Russell, John A	University Of Wisconsin-Madison United States	Treatment of Functional Deficits IN tongue muscles induced by radiation and chemoradiation treatment	5R37CA225608-07	Cecilia Lee, Dr.P.H., RN
Salvemini, Daniela	Saint Louis University United States	A3AR agonists as a novel approach to mitigate chemotherapy induced neurotoxicity	5R01CA230512-05	Rachel Altshuler, Ph.D.
Salvemini, Daniela	Saint Louis University United States	Fingolimod and Ozanimod for the treatment and prevention of chemobrain	5R01CA261979-03	Rachel Altshuler, Ph.D.
Schenker, Yael	University Of Pittsburgh At Pittsburgh United States	Patient-centered and efficacious advance care planning in cancer: the PEACe comparative effectiveness trial	5R01CA235730-06	Brennan Streck, Ph.D., RN, M.P.H.
Shelby, Rebecca A	Duke University United States	Persistent Post-Mastectomy Pain: Randomized Clinical Trial of Targeted Pain Coping Skills Training (Targeted-PCST) with Mediational Analysis	5R01CA249959-05	Brennan Streck, Ph.D., RN, M.P.H.
Shen, Chan	Pennsylvania State Univ Hershey Med Ctr United States	The effects of hydrocodone rescheduling on pain management of older lung cancer patients	1R21CA277849-01	Rachel Altshuler, Ph.D.
Simone, Donald	University Of Minnesota United States	Neural Mechanisms of Cancer Pain	5R01CA241627-05	Rachel Altshuler, Ph.D.
Smith, Ellen Mary Lavoie	University Of Alabama At Birmingham United States	Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study	5R01CA235726-07	Brennan Streck, Ph.D., RN, M.P.H.
Somers, Tamara J	Duke University United States	A Mobile Health Behavioral Pain Intervention Protocol for Breast Cancer Patients with Pain in Medically Underserved Communities: A Randomized Controlled Trial	5R01CA237892-05	Brennan Streck, Ph.D., RN, M.P.H.
Spiegel, Brennan	Cedars-Sinai Medical Center United States	Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes	5R01CA252211-05	Rachel Altshuler, Ph.D.
Staff, Nathan P	Mayo Clinic Rochester United States	Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity	5R01CA275870-03	Rachel Altshuler, Ph.D.
Tamrazi, Benita	Children'S Hospital Of Los Angeles United States	Brain iron accumulation as an in vivo quantifiable biomarker of neurocognitive dysfunction in pediatric brain tumor survivors	5R21CA262978-02	Rachel Altshuler, Ph.D.